Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present VentriPoint Diagnostics Ltd. (OTC: VPTDF).

Full DD Report for VPTDF

You must become a subscriber to view this report.


Recent News from (OTC: VPTDF)

Ventripoint Performs Live Demonstrations of the Next-Generation VMS+ System at EuroEcho 2018
(via TheNewswire) Toronto, Ontario / TheNewswire / December 14, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT, OTCQB:VPTDF ) is pleased to announce that it showcased the VMS+ 3.0 System at EuroEcho 2018 in Milan, Italy, one of the world'...
Source: TheNewsWire
Date: December, 14 2018 07:00
Ventripoint Announces CEO to Give Medical Keynote Presentation at Wall Street Conference in January and Engagement of Lyons Capital LLC
(via TheNewswire) Toronto, Ontario / TheNewswire / December 13, 2018 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company ") (TSXV:VPT, OTCQB:VPTDF) announces that it has entered into a contract with Lyons Capital LLC. ("Lyons") for a Platinum Sponsorship...
Source: TheNewsWire
Date: December, 13 2018 16:48
Ventripoint to Exhibit the Next-Generation VMS+ System at EuroEcho in Milan, Italy
(via TheNewswire) Toronto, Ontario / TheNewswire / November 29, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT, OTCQB:VPTDF ) is pleased to announce that it will be exhibiting at EuroEcho 2018, the annual congress of the European Association...
Source: TheNewsWire
Date: November, 29 2018 07:00
Ventripoint Diagnostics Announces Extension of Warrants
(via TheNewswire) Toronto, Ontario / TheNewswire / November 28, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSXV:VPT) announces that it has applied to the TSX Venture Exchange (the "TSXV") to amend the expiry date of common share purchase warrants...
Source: TheNewsWire
Date: November, 28 2018 16:00
HDZ NRW Heart and Diabetes Center in Germany has Begun Using VMS+ Software for Left Ventricular Volumetric Analysis
(via TheNewswire) Toronto / TheNewswire / November 20, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT, OTCQB:VPTD F ) is pleased to announce that Dr. Kai Thorsten Laser, an internationally renowned pediatric cardiologist at the HDZ NRW ...
Source: TheNewsWire
Date: November, 20 2018 07:00
Ventripoint's Product Offering is Now Extended to Include VMS+ Software for the Analysis of 3D Echo Studies
(via TheNewswire) Toronto, Ontario / TheNewswire / November 19, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT, OTCQB:VPTDF ) is pleased to announce that the VMS+ Software approved for all 4 chambers of the heart can be used for the analysis...
Source: TheNewsWire
Date: November, 19 2018 08:25
Ventripoint Has Been Approved for Government Support to Aid in the Extension of VMS Technology to Provide 4D Data
(via TheNewswire) Toronto, Ontario / TheNewswire / November 14, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce that it has entered into a Contribution Agreement with the Government of Canada. The National Research Counci...
Source: TheNewsWire
Date: November, 14 2018 07:00
St. Michael's Hospital, a Leading Cardiac Centre in Canada, Orders the Ventripoint Artificial Intelligence VMS+ Complete Heart Analysis System
(via TheNewswire) Toronto, Ontario / TheNewswire / November 12, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce that St. Michael's Hospital in Toronto, Canada, has ordered the AI based VMS+ complete heart analysis system ...
Source: TheNewsWire
Date: November, 12 2018 07:00
The University of Chicago Medical Center Cardiac Department Evaluates the VMS+ Complete Heart Analysis System
(via TheNewswire) Toronto, Ontario / TheNewswire / November 5, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT, OTCQB:VPTDF ) is pleased to announce that the University of Chicago Medical Center in Chicago, Illinois will be receiving the VMS+...
Source: TheNewsWire
Date: November, 05 2018 08:00
Ventripoint is Now Listed on the OTCQB in the United States
(via TheNewswire) Toronto, Ontario / TheNewswire / October 24, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV: VPT, OTCQB: VPTDF) is pleased to announce that, as of October 23, 2018, the Company's common shares are now trading on the OTCQB Ventur...
Source: TheNewsWire
Date: October, 24 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-180.11730.11730.11730.117310,000
2018-12-17N/A0.12N/AN/A0
2018-12-14N/A0.12N/AN/A0
2018-12-13N/A0.12N/AN/A0
2018-12-12N/A0.12N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-2610,00010,000100.0000Short
2018-11-1256,500107,46052.5777Short
2018-10-08300300100.0000Short
2018-09-2820,00020,000100.0000Short
2018-09-2715,00015,000100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on VPTDF.


About VentriPoint Diagnostics Ltd. (OTC: VPTDF)

Logo for VentriPoint Diagnostics Ltd. (OTC: VPTDF)

A medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease.

 

Contact Information

 

 

Current Management

  • George Adams / CEO, President, IR
  • Ellen Briant / CFO
  • George Adams /
  • Danny DallaLonga /

Current Share Structure

     



    Daily Technical Chart for (OTC: VPTDF)

    Daily Technical Chart for (OTC: VPTDF)


    Stay tuned for daily updates and more on (OTC: VPTDF)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: VPTDF)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VPTDF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of VPTDF and does not buy, sell, or trade any shares of VPTDF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/